ANDREW D BADLEY, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 34743
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about ANDREW D BADLEY at bizstanding.comMayo Clinic - Andrew D Badley MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Infectious Disease Physicians & Surgeons
Phone:
(507) 284-2511 (Phone)
Professional information
Andrew D Badley, Rochester MN
Specialties:
Infectious Disease Specialist
Address:
200 1St St Sw, Rochester, MN 55905
Education:
Dalhousie University, Faculty of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Dr. Andrew D Badley, Rochester MN - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Infectious Disease, 2007, Internal Medicine, 1994
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
Education:
Medical School
Dalhousie University Faculty Of Medicine
Graduated: 1990
Dalhousie University
Graduated: 1991
Mayo Clinic Rochester
Graduated: 1994
Dalhousie University Faculty Of Medicine
Graduated: 1990
Dalhousie University
Graduated: 1991
Mayo Clinic Rochester
Graduated: 1994
Andrew David Badley, Rochester MN
Specialties:
General Practice, Infectious Disease
Work:
Mayo Clinic
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
Dalhousie University Faculty Of Medicine (1990)
Method Of Increasing Thymic Output In Hiv-Negative Patients By Treatment With Antiretroviral Agents
US Patent:
8093234, Jan 10, 2012
Filed:
Oct 13, 2006
Appl. No.:
11/580359
Inventors:
Andrew D. Badley - Rochester MN, US
Stacey A. R. Vlahakis - Rochester MN, US
Stacey A. R. Vlahakis - Rochester MN, US
Assignee:
Mayo Foundation For Medical Education and Research - Rochester MN
International Classification:
A01N 43/00, A61K 31/33
US Classification:
514183
Abstract:
A method of increasing thymic output in an HIV-negative patient, comprising the steps of (a) identifying a HIV-negative patient who is in need of increased thymic output and (b) supplying an effective amount of antiretroviral agent to the patient such that the patient has an increase in naïve T-cells.
Immunodeficiency Viruses
US Patent:
2010006, Mar 11, 2010
Filed:
Dec 14, 2006
Appl. No.:
12/097473
Inventors:
Andrew D. Badley - Rochester MN, US
Gary D. Bren - Chatfield MN, US
Zilin Nie - Rochester MN, US
Gary D. Bren - Chatfield MN, US
Zilin Nie - Rochester MN, US
International Classification:
G01N 33/53, C07K 16/00, C12N 9/96, C12N 5/00, C12Q 1/34
US Classification:
435 792, 5303879, 5303913, 435188, 435325, 435346, 435 18
Abstract:
This document relates to methods and materials involved in detecting, monitoring, and prognosing immunodeficiency virus infections. For example, methods and materials for determining whether or not a mammal (e.g., a human) has an immunodeficiency virus infection (e.g., an HIV infection), methods and materials for determining whether or not a mammal with an immunodeficiency virus infection is improving, and methods and materials for determining whether or not a mammal with an immunodeficiency virus infection has an advanced immunodeficiency virus infection are provided.
Methods Of Reducing Trail-Induced Apoptosis By Trail Isoforms
US Patent:
2012003, Feb 9, 2012
Filed:
Jul 25, 2011
Appl. No.:
13/190068
Inventors:
Andrew D. Badley - Rochester MN, US
Gary D. Bren - Chatfield MN, US
David J. Schnepple - Crofton MD, US
Gary D. Bren - Chatfield MN, US
David J. Schnepple - Crofton MD, US
International Classification:
A61K 38/17, A61P 43/00
US Classification:
514 189
Abstract:
This document provides to methods and materials related to apoptosis. For example, methods and materials for modulating apoptosis are provided. In addition, methods and materials for treating a mammal having an apoptosis-associated condition are provided.
Methods Of Reducing Trail-Induced Apoptosis By Trail Isoforms
US Patent:
2012032, Dec 20, 2012
Filed:
Aug 22, 2012
Appl. No.:
13/592093
Inventors:
Andrew D. Badley - Rochester MN, US
Gary D. Bren - Chatfield MN, US
David J. Schnepple - Crofton MD, US
Gary D. Bren - Chatfield MN, US
David J. Schnepple - Crofton MD, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
C07K 16/24, C07K 16/46
US Classification:
5303873, 5303892, 5303879, 53038823, 53038815
Abstract:
This document provides to methods and materials related to apoptosis. For example, methods and materials for modulating apoptosis are provided. In addition, methods and materials for treating a mammal having an apoptosis-associated condition are provided.
Methods And Materials Related To Trail Isoforms
US Patent:
2010017, Jul 8, 2010
Filed:
Aug 2, 2007
Appl. No.:
12/376430
Inventors:
Andrew D. Badley - Rochester MN, US
Gary D. Bren - Chatfield MN, US
David J. Schnepple - Crofton MD, US
Gary D. Bren - Chatfield MN, US
David J. Schnepple - Crofton MD, US
International Classification:
A61K 38/16, A61K 38/08, C07H 21/04, C07K 16/18, A61K 39/395, A61P 13/08, A61P 35/00, A61P 31/18, A61P 1/16, A61P 3/10, A61K 38/02
US Classification:
4241581, 530350, 530327, 536 235, 5303879, 514 2
Abstract:
This document provides to methods and materials related to apoptosis. For example, methods and materials for modulating apoptosis are provided. In addition, methods and materials for treating a mammal having an apoptosis-associated condition are provided.